TrialJournal of neuro-oncology2023

Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.

Megan Mantica et al.PubMed ↗Publisher ↗

No numbers read from the abstract.